An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...

Chronic obstructive pulmonary disease (COPD ... Emphysema causes damage to the lungs’ air sacs, called alveoli. A person usually has about 300 million alveoli in the lungs.

extending into the alveoli as BOOP. For CB obliterans, the chest radiograph is often normal, there are early inspiratory crackles and there is irreversible airflow obstruction by pulmonary ...

Pulmonary alveolar proteinosis (PAP ... The condition causes substances such as fats and proteins to accumulate in the alveoli, the ‘air sacs’ of the lung, where oxygen and carbon dioxide ...

IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

called alveoli. Studies in mice revealed that by altering the clock mechanism it was possible to disrupt the fibrotic process making the animals more likely to develop pulmonary fibrosis. The ...

Alveolus’ program is exploring that versatility by studying the candidate in COPD, BPD, pulmonary fibrosis, and injury secondary to viral illness. The company also has a small-molecule treatment ...

As a result, an excess of surfactant accumulates in the alveoli, causing impaired gas ... in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered ...